Harnessing nanotechnology for cancer treatment
Jiajun Zhu,
No information about this author
H. H. Lee,
No information about this author
Rong Huang
No information about this author
et al.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 20, 2025
Nanotechnology
has
become
a
groundbreaking
innovation
force
in
cancer
therapy,
offering
innovative
solutions
to
the
limitations
of
conventional
treatments
such
as
chemotherapy
and
radiation.
By
manipulating
materials
at
nanoscale,
researchers
have
developed
nanocarriers
capable
targeted
drug
delivery,
improving
therapeutic
efficacy
while
reducing
systemic
toxicity.
Nanoparticles
like
liposomes,
dendrimers,
polymeric
nanomaterials
shown
significant
promise
delivering
chemotherapeutic
agents
directly
tumor
sites,
enhancing
bioavailability
minimizing
damage
healthy
tissues.
In
addition
with
utilization
tools
quantum
dots
nanosensors
that
enables
more
precise
identification
biomarkers,
nanotechnology
is
also
playing
pivotal
role
early
detection
diagnosis.
Furthermore,
nanotechnology-based
strategies,
including
photothermal
gene
therapy
immunotherapy
are
novel
ways
combat
by
selectively
targeting
cells
immune
response.
Nevertheless,
despite
these
progressions,
obstacles
still
persist,
particularly
clinical
translation
technologies.
Issues
nanoparticle
toxicity,
biocompatibility,
complexity
regulatory
approval
hinder
widespread
adoption
nanomedicine
oncology.
This
review
discusses
different
applications
highlighting
its
potential
hurdles
implementation.
Future
research
needs
concentrate
on
addressing
unlock
full
providing
personalized,
effective,
minimally
invasive
treatments.
Language: Английский
Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities—A State-of-the-Art Review
Dominika Kunachowicz,
No information about this author
Karolina Kłosowska,
No information about this author
N. Sobczak
No information about this author
et al.
Nanomaterials,
Journal Year:
2024,
Volume and Issue:
14(17), P. 1424 - 1424
Published: Aug. 31, 2024
The
increasing
incidence
of
breast
cancers
(BCs)
in
the
world
population
and
their
complexity
high
metastatic
ability
are
serious
concerns
for
healthcare
systems.
Despite
significant
progress
medicine
made
recent
decades,
efficient
treatment
invasive
still
remains
challenging.
Chemotherapy,
a
fundamental
systemic
method,
is
burdened
with
severe
adverse
effects,
efficacy
limited
by
resistance
development
risk
disease
recurrence.
Also,
current
diagnostic
methods
have
certain
drawbacks,
attracting
attention
to
idea
developing
novel,
more
sensitive
detection
therapeutic
modalities.
It
seems
solution
these
issues
can
be
provided
nanotechnology.
Particularly,
quantum
dots
(QDs)
been
extensively
evaluated
as
potential
targeted
drug
delivery
vehicles
and,
simultaneously,
sensing
bioimaging
probes.
These
fluorescent
nanoparticles
offer
unlimited
possibilities
surface
modifications,
allowing
attachment
biomolecules,
such
antibodies
or
proteins,
molecules,
among
others.
In
this
work,
we
discuss
applicability
QDs
cancer
diagnostics
light
knowledge.
We
begin
introducing
molecular
histopathological
features
BCs,
standard
regimens,
methods.
Further,
QDs,
along
uptake,
biodistribution
patterns,
cytotoxicity,
described.
Based
on
reports
published
years,
present
research
possible
QD
use
improving
BC
chemotherapeutic
photosensitizing
agents,
stages
development.
also
address
limitations
open
questions
regarding
topic.
Language: Английский
In Situ Fabricated Perovskite Quantum Dots: From Materials to Applications
Xian‐gang Wu,
No information about this author
Yuyu Jing,
No information about this author
Haizheng Zhong
No information about this author
et al.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 17, 2024
Due
to
the
low
formation
enthalpy
and
high
defect
tolerance,
in
situ
fabricated
perovskite
quantum
dots
offer
advantages
such
as
easy
fabrication
superior
optical
properties.
This
paper
reviews
methodologies,
functional
materials
of
dots,
including
polymer
nanocomposites,
doped
glasses,
mesoporous
dots-embedded
single
crystals,
electroluminescent
films.
study
further
highlights
industrial
breakthroughs
especially
scale-up
stability
enhancement.
Finally,
fundamental
challenges
developing
for
applications
are
discussed,
with
a
focus
on
photoinduced
degradation
under
high-intensity
light
irradiation,
ion
migration
electrical
bias
thermal
quenching
at
temperature.
Language: Английский
Influence of experimental conditions on the adsorption of disease biomarker proteins to InP/ZnS quantum dots
Nathaniel Alan Gomez,
No information about this author
Daniel Blumel,
No information about this author
Davies Dueñas
No information about this author
et al.
Analytical Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 115903 - 115903
Published: May 1, 2025
Language: Английский
Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
Mingqin Shi,
No information about this author
Xinyao Li,
No information about this author
Liwei Xing
No information about this author
et al.
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1556 - 1556
Published: Dec. 4, 2024
Polycystic
ovary
syndrome
(PCOS)
is
the
predominant
endocrine
disorder
among
women
of
reproductive
age
and
represents
leading
cause
anovulatory
infertility,
which
imposes
a
considerable
health
economic
burden.
Currently,
medications
used
to
treat
PCOS
can
lead
certain
adverse
reactions,
such
as
affecting
fertility
increasing
risk
venous
thrombosis.
Drug
delivery
systems
utilizing
nanomaterials,
characterized
by
prolonged
half-life,
precision-targeted
delivery,
enhanced
bioavailability,
reduced
toxicity,
are
currently
being
employed
in
management
PCOS.
This
innovative
approach
gaining
traction
favored
strategy
for
augmenting
therapeutic
efficacy
medications.
Consequently,
this
paper
discusses
roles
nanoparticles,
nanocarriers,
targeted
ligands
within
nanomaterial-based
drug
systems,
aiming
identify
optimal
methodologies
treating
using
nanomaterials.
Additionally,
prospective
research
avenues
concerning
context
PCOS,
well
implications
existing
insights
on
advancement
novel
therapies
highlighted.
Language: Английский